Eledon Pharmaceuticals, Inc. (BOATS:ELDN) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock and pre-funded warrants Closed: US$57.5M raised · US$1.65 a share · Leerink Partners +2 Dealers: Leerink Partners (co-lead), Cantor (co-lead), LifeSci Capital (co-lead) Use of proceeds: Advance tegoprubart programs in kidney transplantation, islet cell transplantation and xenotransplantation | Nov 14, 2025 |